Alkermes Inc. is recalling 6,514 units of Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial kits. The recall was initiated because 1-inch needles were accidentally placed inside cardboard sleeves labeled as 1.5-inch administration needles. While the medication vial itself is not impacted, using the incorrect needle length may affect the proper administration of the medication. These prescription kits were distributed nationwide across the United States.
The use of a shorter 1-inch needle when a 1.5-inch needle is required may result in the medication being injected into the wrong tissue layer, potentially affecting how the drug is absorbed or causing local injection site reactions.
Healthcare provider consultation and pharmacy return
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.